HF
TNYA icon

HRT Financial’s Tenaya Therapeutics TNYA Stock Holding History

HRT Financial’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34,310
Closed -$20K – 3677
2025
Q2 		$20K Buy
+34,310
New +$17.5K ﹤0.01% 2401
2023
Q4 		– Sell
-12,018
Closed -$30K – 3088
2023
Q3 		$30K Buy
+12,018
New +$50.3K ﹤0.01% 2037

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

HRT Financial's TNYA Position: Q3 2025 in Review

HRT Financial sold out of Tenaya Therapeutics (TNYA) in Q3 2025, closing a stake of 34,310 shares — an estimated $20K sold.

HRT Financial first reported a position in TNYA in Q3 2023 and held it in 2 quarters. The position peaked at $30K in Q3 2023. 91 funds tracked by Wall St. Rank hold TNYA as of Q3 2025.

  • HRT Financial reported no remaining Tenaya Therapeutics position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 34,310 Tenaya Therapeutics shares in Q3 2025, an estimated $20K.
  • HRT Financial first reported a position in Tenaya Therapeutics in Q3 2023 and held it in 2 quarters.
  • HRT Financial's Tenaya Therapeutics position peaked at $30K in Q3 2023.
  • 91 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.